EARNINGS WATCH- Integrated Diagnostics Holdings (IDH) reported a 26% y-o-y increase in net profits to EGP 356 mn in 9M2018, according a regulatory filing (pdf). The consumer healthcare company’s 9M2018 revenues were up 25% y-o-y to EGP 1.38 bn. IDH’s focus on marketing efforts and test mix has “seen us extract higher value from increasing patient and test volumes,” which has allowed the company to deliver “outstanding profitability” despite of operating challenges, including double-digit inflation, devaluation in Sudan, and investment costs associated with growing and integrating its newly acquired Nigerian operation the company’s platform, said IDH CEO Hend El Sherbini.